Rocket Pharmaceuticals: Q2 Earnings Snapshot

Carbonatix Pre-Player Loader

Audio By Carbonatix

CRANBURY, N.J. (AP) — CRANBURY, N.J. (AP) — Rocket Pharmaceuticals Inc. (RCKT) on Thursday reported a loss of $65.7 million in its second quarter.

On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 82 cents.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 80 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RCKT at https://www.zacks.com/ap/RCKT

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • AM970 Special Programming
    11:00PM - 12:00AM
     
    AM970 Special Programming
     
  • Radiosurgery New York
    12:00AM - 3:00AM
     
    Don’t miss Radiosurgery New York with Dr. Gil Lederman on AM 970 The Answer.
     
  • Hollywood 360
    3:00AM - 7:00AM
     
    Spend time with Carl Amari as he showcases Hollywood's past and present. Carl   >>
     

See the Full Program Guide